Drew Ferguson

About Drew Ferguson

Currently SVP, Chief Accounting Officer at Worldwide Clinical TrialsPRIORTwo+ years as VP, Finance and Accounting at Paradigm Health. Two+ years as Corporate Controller for a $7B+ publicly-traded contract research organization. Oversight of the team supporting- Corporate Accounting (Debt, Equity, etc.)- Consolidation and Financial Reporting- Technical Accounting - Stock Compensation AdministrationSix months as Finance Business Partner for Site and Patient Recruitment (SPS) business. Two+ years experience as Senior Director of FP & A- Execution of the annual consolidated budgeting process culminating with executive and board approval - Ongoing oversight of financial performance against plan, including analysis of actual results and identification of changes to forward-looking expectations - Primary corporate finance liaison with business unit executives regarding actual and forecasted results, as well as resource requirements - Advising executive management on risks/opportunities and resource allocation prioritization - Supporting strategic corporate development initiatives (financing, M&A) Five+ years as the Senior Director of Internal Audit and Chief Audit Executive (CAE) at PRA Health Sciences- Developing, planning, executing and reporting results of the annual Internal Audit Plan to the Audit Committee of the Board of Directors- Oversight of the design and effectiveness evaluation supporting management’s opinion on the effectiveness of internal control over financial reporting (SOX)- Execution of auditing and monitoring activities supporting ABAC and CAS compliance programs - Consultation with management to design and implement effective controls over the security, availability and confidentiality of critical systems supporting the conduct of clinical trials (SOC2)- Supporting management’s prioritization and capital allocation across all compliance programs - Led a cross-functional acquisition integration team(Symphony Health) Ten years of experience at EY serving public and private clients in a variety of industries- SEC accounting and reporting issues (M&A, debt and equity transactions, SOX 404)- Registration statements and offerings such as IPOs, debt and equity registration statements, and related comfort letter procedures- SEC filings (Form S-1, Form S-3, Form S-8, Form 10-K, Form 10-Q)

Experience

1. SVP, Chief Accounting Officer

   Worldwide Clinical Trials

   Oct 2025 — Present · Raleigh, NC, US

Education

• UNC Kenan-Flagler Business School

  B.S. in Business Administration

  2000 — 2004

• UNC Kenan-Flagler Business School

  Master of Accounting

  2004 — 2005

Skills

• Internal Controls
• Sec Filings
• Corporate Tax
• External Audit
• Sarbanes-Oxley
• Assurance
• Sarbanes-Oxley Act
• Tax Accounting
• Cpa
• Us Gaap
• Big 4
• Gaap
• Financial Reporting